add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News » Cornerstone BioPharma closes on Critical Therapeutics merger

November 3, 2008

Cornerstone BioPharma closes on Critical Therapeutics merger

Filed under: Other Regional News — admin @ 1:16 pm

CARY, NC - Cornerstone BioPharma Holdings Inc., a specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders, has completed its merger with Critical Therapeutics Inc., a biopharmaceutical company focused on developing and commercializing innovative products for respiratory and inflammatory diseases.

The combined company has been renamed Cornerstone Therapeutics Inc. and will continue to trade on The NASDAQ Capital Market under the ticker symbol “CRTX”.

Craig A. Collard, president and chief executive officer of Cornerstone BioPharma, will be president and CEO of the combined company. Brian Dickson, M.D., chief medical officer of Cornerstone BioPharma, will be the chief medical officer of the combined company.

http://www.techjournalsouth.com/news/article.html?item_id=6384

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment